Announcing a new article publication for Zoonoses journal. Methicillin resistant Staphylococcus aureus (MRSA) and Vancomycin ...
DoseMe, a leader in model-informed precision dosing (MIPD), today announced that Senior Care Partners (PACE) has implemented DoseMeRx to modernize vancomycin dosing in alignment with Area Under the ...
V-161, a novel compound targeting the Na+ -V-ATPase enzyme in vancomycin-resistant Enterococcus faecium (VRE), significantly reduces bacterial growth and colonization.
A recent study by a team from Chiba University has demonstrated a promising approach for fighting antibiotic resistance by identifying a compound, V-161, that inhibits a sodium-pumping enzyme critical ...
The major objective of this research collaboration is to develop new therapeutic drug candidates which target antimicrobial resistant pathogens. This work will utilize the Immuron technology platform, ...
Vancomycin-resistant enterococci. Julien Ferrari, PhD, and Thomas Rotolo, PhD, of ApotheCom provided assistance in drafting and editing the manuscript. Cubist Pharmaceuticals, Inc., supported the ...